@article{garcia_rodriguez_risk_2004,
	title = {Risk of breast cancer among users of aspirin and other anti-inflammatory drugs},
	volume = {91},
	issn = {0007-0920},
	doi = {10.1038/sj.bjc.6602003},
	abstract = {We conducted a cohort study with a nested case-control analysis to evaluate the effect of anti-inflammatory drugs in breast cancer incidence using the General Practice Research Database. Women taking aspirin and paracetamol for 1 year or longer had an odds ratio (OR) of 0.77 (95 percent confidence interval (95\% CI): 0.62,0.95) and 0.76 (95\% CI: 0.65,0.88), respectively, compared to nonusers. Daily doses of aspirin (75 mg) and paracetamol (up to 2000 mg) showed the greatest reduced risk. Use of non-aspirin nonsteroidal anti-inflammatory drugs for more than 1 year was not associated with a reduced risk of breast cancer (OR=1.00 (95\% CI: 0.84, 1.17), and the corresponding estimate among users with at least 2 years duration was similar. Our findings suggest that aspirin at cardioprophylactic doses as well as paracetamol at analgesic doses is associated with a reduced risk of breast cancer.},
	language = {eng},
	number = {3},
	journal = {British Journal of Cancer},
	author = {García Rodríguez, L. A. and González-Pérez, A.},
	month = aug,
	year = {2004},
	pmid = {15226764},
	pmcid = {PMC2409835},
	keywords = {Adult, Aged, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Breast Neoplasms, Case-Control Studies, Cohort Studies, Databases, Factual, Female, Humans, Middle Aged, Odds Ratio, Risk Assessment},
	pages = {525--529}
}

{"_id":"cHAEaaz6ocKW8MZ9N","bibbaseid":"garcarodrguez-gonzlezprez-riskofbreastcanceramongusersofaspirinandotherantiinflammatorydrugs-2004","downloads":0,"creationDate":"2017-08-15T09:38:10.836Z","title":"Risk of breast cancer among users of aspirin and other anti-inflammatory drugs","author_short":["García Rodríguez, L. A.","González-Pérez, A."],"year":2004,"bibtype":"article","biburl":"http://bibbase.org/zotero/veegee78","bibdata":{"bibtype":"article","type":"article","title":"Risk of breast cancer among users of aspirin and other anti-inflammatory drugs","volume":"91","issn":"0007-0920","doi":"10.1038/sj.bjc.6602003","abstract":"We conducted a cohort study with a nested case-control analysis to evaluate the effect of anti-inflammatory drugs in breast cancer incidence using the General Practice Research Database. Women taking aspirin and paracetamol for 1 year or longer had an odds ratio (OR) of 0.77 (95 percent confidence interval (95% CI): 0.62,0.95) and 0.76 (95% CI: 0.65,0.88), respectively, compared to nonusers. Daily doses of aspirin (75 mg) and paracetamol (up to 2000 mg) showed the greatest reduced risk. Use of non-aspirin nonsteroidal anti-inflammatory drugs for more than 1 year was not associated with a reduced risk of breast cancer (OR=1.00 (95% CI: 0.84, 1.17), and the corresponding estimate among users with at least 2 years duration was similar. Our findings suggest that aspirin at cardioprophylactic doses as well as paracetamol at analgesic doses is associated with a reduced risk of breast cancer.","language":"eng","number":"3","journal":"British Journal of Cancer","author":[{"propositions":[],"lastnames":["García","Rodríguez"],"firstnames":["L.","A."],"suffixes":[]},{"propositions":[],"lastnames":["González-Pérez"],"firstnames":["A."],"suffixes":[]}],"month":"August","year":"2004","pmid":"15226764","pmcid":"PMC2409835","keywords":"Adult, Aged, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Breast Neoplasms, Case-Control Studies, Cohort Studies, Databases, Factual, Female, Humans, Middle Aged, Odds Ratio, Risk Assessment","pages":"525--529","bibtex":"@article{garcia_rodriguez_risk_2004,\n\ttitle = {Risk of breast cancer among users of aspirin and other anti-inflammatory drugs},\n\tvolume = {91},\n\tissn = {0007-0920},\n\tdoi = {10.1038/sj.bjc.6602003},\n\tabstract = {We conducted a cohort study with a nested case-control analysis to evaluate the effect of anti-inflammatory drugs in breast cancer incidence using the General Practice Research Database. Women taking aspirin and paracetamol for 1 year or longer had an odds ratio (OR) of 0.77 (95 percent confidence interval (95\\% CI): 0.62,0.95) and 0.76 (95\\% CI: 0.65,0.88), respectively, compared to nonusers. Daily doses of aspirin (75 mg) and paracetamol (up to 2000 mg) showed the greatest reduced risk. Use of non-aspirin nonsteroidal anti-inflammatory drugs for more than 1 year was not associated with a reduced risk of breast cancer (OR=1.00 (95\\% CI: 0.84, 1.17), and the corresponding estimate among users with at least 2 years duration was similar. Our findings suggest that aspirin at cardioprophylactic doses as well as paracetamol at analgesic doses is associated with a reduced risk of breast cancer.},\n\tlanguage = {eng},\n\tnumber = {3},\n\tjournal = {British Journal of Cancer},\n\tauthor = {García Rodríguez, L. A. and González-Pérez, A.},\n\tmonth = aug,\n\tyear = {2004},\n\tpmid = {15226764},\n\tpmcid = {PMC2409835},\n\tkeywords = {Adult, Aged, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Breast Neoplasms, Case-Control Studies, Cohort Studies, Databases, Factual, Female, Humans, Middle Aged, Odds Ratio, Risk Assessment},\n\tpages = {525--529}\n}\n\n","author_short":["García Rodríguez, L. A.","González-Pérez, A."],"key":"garcia_rodriguez_risk_2004","id":"garcia_rodriguez_risk_2004","bibbaseid":"garcarodrguez-gonzlezprez-riskofbreastcanceramongusersofaspirinandotherantiinflammatorydrugs-2004","role":"author","urls":{},"keyword":["Adult","Aged","Anti-Inflammatory Agents","Non-Steroidal","Aspirin","Breast Neoplasms","Case-Control Studies","Cohort Studies","Databases","Factual","Female","Humans","Middle Aged","Odds Ratio","Risk Assessment"],"downloads":0},"search_terms":["risk","breast","cancer","users","aspirin","anti","inflammatory","drugs","garcía rodríguez","gonzález-pérez"],"keywords":["adult","aged","anti-inflammatory agents","non-steroidal","aspirin","breast neoplasms","case-control studies","cohort studies","databases","factual","female","humans","middle aged","odds ratio","risk assessment"],"authorIDs":[],"dataSources":["FmCWXwJibZiWNzpdc"]}